

Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1356, 2011-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




Cyclophosphamide/fludarabine/treosulfan: Various toxicities in paediatric patients: 28 case reports
Reactions Weekly, Vol. 1, Iss. 1355, 2011-01 ,pp. :






Cyclophosphamide/fludarabine/rituximab: Hypogammaglobulinaemia: case report
Reactions Weekly, Vol. 1, Iss. 1204, 2008-01 ,pp. :